BestEx Research · 2 days ago
Director of Sales - Algorithmic & Electronic Trading
BestEx Research is an independent execution consulting and analytics firm specializing in algorithmic execution and transaction cost analysis. The Director of Sales will be responsible for originating and developing new client relationships, primarily focusing on futures and exchange-traded derivatives.
AnalyticsEnterprise ApplicationsFinancial ServicesFinTechInformation TechnologyTrading Platform
Responsibilities
Originate, develop, and close new client relationships across futures, exchange-traded derivatives, and electronic trading desks
Build and manage a robust sales pipeline, from lead generation through contract execution
Leverage existing industry relationships while proactively identifying new opportunities
Partner with research and product teams to articulate BestEx’s value proposition around execution quality, algorithmic performance, and market structure
Qualification
Required
7+ years of experience in institutional sales within futures, exchange-traded derivatives, or electronic trading
Proven background in algorithmic execution sales, electronic sales & trading, or related capital markets roles
Demonstrated ability to independently manage complex sales cycles and close new business
Strong communication skills with the ability to engage credibly with senior traders, heads of trading, and execution teams
Preferred
Existing network of buy-side, sell-side, or proprietary trading firm relationships strongly preferred
Benefits
Opportunity to play a key role in scaling a respected, independent execution research firm
High degree of autonomy and visibility within the organization
Competitive compensation structure aligned with performance
Collaborative, intellectually driven environment focused on data, research, and execution excellence
Company
BestEx Research
BestEx Research provides algorithmic trading solutions to asset managers and banks for equities, Fixed Income, commodities, FX and cryptos
Funding
Current Stage
Growth StageTotal Funding
$16.5MKey Investors
QC·VENTURES,Quadrature Capital
2023-03-02Series B· $10M
2020-12-10Series A· $5M
2017-08-01Seed· $1.5M
Recent News
2025-08-29
Company data provided by crunchbase